Act as a World-Class Professor of General Medicine, Clinical Pharmacology, Pathology, and Medical Education. Teach me malaria disease in a simple, exam-oriented, and clinically practical manner. For every disease, follow this format: 1. Definition - One-line exam definition - Simple explanation 2. Causes (Etiology) - Common causes - Important risk factors 3. Types / Classification - Brief explanation of each type 4. Pathophysiology - Step-by-step flowchart with arrows - Easy to understand 5. Clinical Features - Symptoms - Signs - Explain why important symptoms occur 6. Key Symptoms That Suggest the Diagnosis - Hallmark symptom - Classic clinical clues - Red flag findings 7. Laboratory Investigations Create a table: Investigation | Expected Finding | Clinical Significance Include: - CBC - Biochemistry - Disease-specific tests - Imaging findings if relevant 8. Differential Diagnosis Create a comparison table: Disease | Similar Features | Differentiating Features 9. Short Clinical Case Example format: "A 55-year-old male presents with chest pain radiating to the left arm, sweating, and breathlessness. ECG shows ST elevation in leads II, III, and aVF. Troponin-I is elevated." Diagnosis: Reasoning: Provide only 1–2 short high-yield cases. 10. Treatment A. Non-Pharmacological Treatment B. Pharmacological Treatment Create a table: Drug | Drug Group | Mechanism of Action | Indication | Dose | Major Adverse Effects For every disease mention: - Drug of Choice (DOC) - First-line drugs - Alternative drugs - Emergency drugs (if applicable) 11. Clinical Pearls - Important bedside clues - High-yield exam facts - Viva points 12. Common Diagnostic Mistakes - Frequently missed findings - Common confusion with other diseases - How to avoid errors 13. 5-Minute Revision Summary Definition → Causes → Pathophysiology → Symptoms → Investigations → Treatment → Complications Teaching Rules: - Use simple English. - Explain like teaching a final-year medical student. - Use tables and flowcharts. - Focus on practical diagnosis and treatment. - Focus on exam-oriented points. - Mention standard drug doses whenever possible. - Keep the explanation concise but complete.
Reading File
Finding Sources
Searching PubMed
"malaria" AND "treatment"
Searching the Web
malaria WHO treatment guidelines 2025 clinical management
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Reading File
I now have comprehensive, authoritative content from multiple top-tier textbooks (Harrison's 22e, Robbins Pathology, Rosen's Emergency Medicine, Goldman-Cecil, Murray & Nadel). I have the pathophysiology diagram. Let me now compile the complete, detailed teaching module.
MALARIA - Complete Medical Teaching Module
Sources: Harrison's Principles of Internal Medicine 22e (2025) | Robbins & Kumar Basic Pathology | Rosen's Emergency Medicine | Goldman-Cecil Medicine | Murray & Nadel's Respiratory Medicine | WHO Guidelines August 2025
1. DEFINITION
One-line exam definition:
Malaria is a febrile hemolytic illness caused by intracellular protozoan parasites of the genus Plasmodium, transmitted by the bite of the female Anopheles mosquito.
Simple explanation:
A mosquito injects a parasite into your blood → parasite hides in the liver first, then enters red blood cells → destroys RBCs in cycles → causes periodic fever, anemia, and potentially life-threatening organ failure.
2. CAUSES (ETIOLOGY)
Causative Organisms - 5 Species of Plasmodium
| Species | Disease | Fever Cycle | Severity |
|---|---|---|---|
| P. falciparum | Malignant tertian malaria | Every 48 h (but often irregular) | MOST DANGEROUS - high fatality |
| P. vivax | Benign tertian malaria | Every 48 h | Moderate |
| P. ovale | Benign tertian malaria | Every 48 h | Mild |
| P. malariae | Quartan malaria | Every 72 h | Mild (but causes nephrotic syndrome) |
| P. knowlesi | Quotidian malaria | Every 24 h | Can be severe (Southeast Asia) |
Vector
- Female Anopheles mosquito - the ONLY vector (male mosquitoes do not bite)
- Humans are the only natural reservoir
Other (Rare) Routes of Transmission
- Blood transfusion
- Needle sharing (IV drug users)
- Organ transplantation
- Mother-to-fetus (congenital/perinatal)
- "Airport malaria" - infected mosquito travels on a plane
Important Risk Factors
- Travel to or residence in endemic areas (sub-Saharan Africa, South/Southeast Asia, Central/South America, Oceania)
- No chemoprophylaxis or poor compliance
- Children under 5 years
- Pregnant women
- Non-immune travelers
- Immunocompromised patients (HIV/AIDS, transplant recipients)
- Protective factors (exam point): Sickle cell trait (HbAS), G6PD deficiency, thalassemia, Duffy antigen negativity (protects against P. vivax)
3. TYPES / CLASSIFICATION
By Species (Clinical Importance)
| Type | Species | Key Features |
|---|---|---|
| Malignant tertian | P. falciparum | Cerebral malaria, blackwater fever, multiorgan failure, can infect ALL ages of RBCs, no dormant liver stage |
| Benign tertian | P. vivax | Relapses due to hypnozoites in liver; infects only young RBCs (reticulocytes) |
| Benign tertian | P. ovale | Similar to vivax; relapses; West Africa predominant |
| Quartan | P. malariae | 72-h cycle; infects only old RBCs; causes immune complex nephropathy |
| Simian/Knowlesi | P. knowlesi | Southeast Asia; misread as P. malariae on smear; can be rapidly severe |
By Severity (WHO Classification)
- Uncomplicated malaria - symptomatic but no severe organ impairment
- Severe malaria - any of the WHO severity criteria present (see Section 6)
4. PATHOPHYSIOLOGY
Life Cycle Diagram
Life cycle of P. falciparum (Robbins & Kumar Basic Pathology)
Step-by-Step Pathophysiology
Female Anopheles mosquito bites human
↓
Sporozoites injected into bloodstream
(Circumsporozoite protein + Thrombospondin-related adhesive protein
bind to hepatocyte proteoglycans)
↓
HEPATIC STAGE (1-4 weeks, clinically silent)
Sporozoites → enter hepatocytes → differentiate into merozoites
[P. vivax / P. ovale also form HYPNOZOITES = dormant liver forms → cause RELAPSE]
↓
Hepatocytes rupture → merozoites released into blood
↓
ERYTHROCYTIC STAGE (causes clinical disease)
Merozoite lectin-like molecule binds glycophorin (sialic acid residue) on RBCs
→ Merozoite invaginates into RBC within a "digestive vacuole"
→ Differentiates into RING TROPHOZOITE → TROPHOZOITE → SCHIZONT
↓
Two paths from trophozoite:
Path 1: → GAMETOCYTES → restart mosquito cycle (sexual stage)
Path 2: → SCHIZONTS → express PfEMP1 (P. falciparum Erythrocyte Membrane Protein 1)
→ PfEMP1 forms KNOBS on RBC surface
→ Knobs bind endothelial ICAM-1, VCAM-1, CD36
→ SEQUESTRATION of infected RBCs in capillary beds
↓
Schizonts → 16-32 new merozoites → RBC LYSES → new RBCs infected
(this rupture = FEVER SPIKE with TNF, IL-1, IL-6 release)
↓
CONSEQUENCES OF SEQUESTRATION (P. falciparum only):
├── BRAIN → Cerebral malaria (microvascular sludging, ischemia)
├── KIDNEY → Acute tubular necrosis, renal failure
├── PLACENTA → Poor fetal outcomes
└── LUNG → ARDS / pulmonary edema
↓
ANEMIA:
1. Direct RBC lysis by merozoites
2. Immune destruction of uninfected RBCs (antibody-mediated)
3. Spleen-mediated hemolysis
4. Inhibition of erythropoietin
↓
BLACKWATER FEVER (severe hemolysis → hemoglobinuria → renal failure)
Why Fever is Periodic
- Fever corresponds to synchronous rupture of schizonts releasing merozoites + malarial pigment (hemozoin) + pyrogens (TNF-α, IL-1, IL-6)
- Each schizont cycle takes a fixed time → periodic fever pattern
- P. falciparum often loses synchrony → continuous or irregular fever
5. CLINICAL FEATURES
Classic Malarial Paroxysm (3 Stages - Exam Favorite!)
COLD STAGE (15-60 min)
Intense chills, rigors, teeth chattering, vasoconstriction
↓
HOT STAGE (2-6 hours)
High fever (39-41°C), headache, vomiting, flushing, delirium
↓
SWEATING STAGE (2-4 hours)
Profuse sweating, fever breaks, patient feels exhausted but better
↓
Symptom-free interval → NEXT PAROXYSM
Symptoms
- Fever (most common - often continuous early, becomes periodic later)
- Headache (>95% sensitivity alongside fever for diagnosis)
- Chills and rigors
- Sweating
- Myalgia and arthralgia
- Nausea, vomiting, diarrhea
- Malaise, fatigue
- Abdominal pain (can mimic acute abdomen)
Signs
- Splenomegaly (chronic malaria - key sign; parasite-laden RBCs trapped in spleen)
- Hepatomegaly (Kupffer cells distended with malarial pigment)
- Pallor / jaundice (hemolytic anemia + hyperbilirubinemia)
- Anemia (can be severe)
- Thrombocytopenia (consistent finding)
Why Key Symptoms Occur
| Symptom | Mechanism |
|---|---|
| Periodic fever | Synchronous schizont rupture → pyrogenic cytokines (TNF-α, IL-1, IL-6) |
| Chills/rigors | TNF-α acts on hypothalamus → temperature set-point rises → shivering to generate heat |
| Anemia | RBC lysis (direct + immune) + suppressed erythropoiesis |
| Jaundice | Hemolysis → unconjugated bilirubin ↑ + hepatic involvement |
| Splenomegaly | Reticuloendothelial hyperplasia + trapping of parasitized RBCs |
| Thrombocytopenia | Splenic sequestration + immune-mediated platelet destruction |
| Headache | Cytokine release + microvascular changes |
6. KEY SYMPTOMS THAT SUGGEST THE DIAGNOSIS
Hallmark Symptom
Periodic fever with chills and rigors in a patient with travel history to endemic area
Classic Clinical Clues
- Travel history to Africa/Asia/South America (MOST important clue)
- Fever + headache + absence of respiratory symptoms (unlike flu)
- Fever + anemia + splenomegaly = classic triad
- Symptoms starting 7-30 days after return from endemic area
WHO Criteria for SEVERE Malaria (Red Flag Findings - Know All!)
| Red Flag | Clinical/Lab Value |
|---|---|
| Cerebral malaria | Altered mental status, GCS < 11, seizures |
| Severe anemia | Hb < 7 g/dL |
| Respiratory distress / ARDS | Respiratory rate ↑, SpO₂ ↓, bilateral opacities on CXR |
| Hypoglycemia | Blood glucose < 40 mg/dL |
| Acute kidney injury | Creatinine > 3 mg/dL or urea > 20 mmol/L |
| Jaundice | Total bilirubin > 3 mg/dL |
| Shock ("algid malaria") | Systolic BP < 80 mmHg |
| DIC / Bleeding | Spontaneous bleeding, prolonged PT/PTT |
| Hemoglobinuria | "Black water" urine (Blackwater fever) |
| Hyperparasitemia | > 2% parasitized RBCs; mortality ↑↑ at > 500,000/μL |
| High lactate | > 5 mmol/L (best prognostic marker along with HCO₃) |
7. LABORATORY INVESTIGATIONS
| Investigation | Expected Finding | Clinical Significance |
|---|---|---|
| CBC - Hemoglobin | Low (normocytic/normochromic initially) | Hemolytic anemia |
| CBC - WBC | Normal or low (leukopenia); leukocytosis in severe disease | Leukocytosis = severe malaria or secondary bacterial infection |
| CBC - Platelets | Thrombocytopenia (very consistent finding) | Splenic sequestration + immune destruction; low platelet is a diagnostic clue |
| Peripheral Blood Smear (THICK film) | Ring trophozoites, schizonts, gametocytes inside RBCs; malarial pigment (hemozoin) | Gold standard for diagnosis; thick film concentrates parasites 40-100x; count 200 WBCs minimum under oil immersion; examine 100-200 fields before calling negative |
| Peripheral Blood Smear (THIN film) | Species identification; morphology of parasitized RBCs | Differentiates species; P. falciparum = multiple rings/cell, banana-shaped gametocytes |
| Rapid Diagnostic Test (RDT) | Detects PfHRP2 (P. falciparum-specific), LDH, aldolase | Quick bedside test; PfHRP2 remains positive for weeks; does NOT quantify parasitemia |
| PCR (Malaria PCR) | Detects Plasmodium DNA | Most sensitive; gold standard for species confirmation; used when smear is negative but suspicion high |
| Serum Bilirubin | Total bilirubin ↑ (mainly unconjugated) | Hemolysis |
| LFTs (AST/ALT) | Mildly elevated (3x ULN in severe disease) | Hepatic involvement |
| Blood Glucose | Hypoglycemia (especially in children, pregnant women, on quinine) | Life-threatening; always check; quinine stimulates insulin release |
| Serum Creatinine / Urea | Elevated in severe malaria | Acute kidney injury |
| Lactate | Elevated (≥ 5 mmol/L in severe) | Best biochemical prognosticator (along with HCO₃) |
| Arterial Blood Gas | Metabolic acidosis (HCO₃ < 15 mmol/L, pH < 7.25) | Lactic acidosis from tissue hypoperfusion |
| Coagulation (PT/PTT/Fibrinogen) | Prolonged PT/PTT, low fibrinogen | DIC in severe malaria |
| Urine Dipstick/UA | Hemoglobinuria ("cola-colored" urine) | Blackwater fever - massive hemolysis |
| Chest X-Ray | Bilateral symmetric opacities (diffuse) | ARDS / noncardiogenic pulmonary edema (mortality > 80%) |
| Blood Culture | May grow gram-negative bacteria in very high parasitemia (> 20%) | Risk of concomitant bacteremia |
Smear Morphology - Species Differentiation (Exam High-Yield)
| Feature | P. falciparum | P. vivax | P. malariae | P. ovale |
|---|---|---|---|---|
| RBC size | Normal or small | Enlarged | Normal/small | Slightly enlarged, oval |
| Multiple rings/cell | Yes (2-3) | No | No | No |
| Schüffner's dots | Absent | Present | Absent | Present |
| Maurer's clefts | Present | Absent | Absent | Absent |
| Gametocyte shape | Banana/crescent | Round/oval | Round | Round |
| Band forms | Absent | Absent | Yes (diagnostic) | Absent |
| % RBCs infected | Up to 30% | < 2% | < 1% | < 2% |
| Fever periodicity | 48 h (irregular) | 48 h | 72 h | 48 h |
8. DIFFERENTIAL DIAGNOSIS
| Disease | Similar Features | Differentiating Features |
|---|---|---|
| Typhoid fever | Fever, headache, splenomegaly, leukopenia | Stepladder fever pattern; rose spots; positive Widal/blood culture; no hemolysis or thrombocytopenia |
| Dengue fever | Fever, thrombocytopenia, headache, myalgia | Rash (maculopapular, "islands of white in sea of red"); positive NS1/IgM; no RBC parasites on smear |
| Bacterial meningitis | Fever, headache, altered consciousness | Neck stiffness, Kernig/Brudzinski signs; CSF pleocytosis; no parasitemia |
| Viral encephalitis | Fever, seizures, altered consciousness | CSF lymphocytosis; viral serology positive; no RBC parasites |
| Enteric fever (Salmonella) | Fever, headache, hepatosplenomegaly | Relative bradycardia; rose spots; culture positive; smear negative |
| Leptospirosis | Fever, jaundice, renal failure, thrombocytopenia | Exposure to contaminated water; calf muscle tenderness; Weil's disease; serology/PCR |
| Viral hepatitis | Jaundice, hepatomegaly, fever | Markedly elevated transaminases; serology positive; no hemolysis; no RBC parasites |
| Sepsis | Fever, shock, multiorgan failure | Source of infection; positive blood culture; no parasitemia |
| Blackwater fever vs. Hemolytic Uremic Syndrome (HUS) | Hemoglobinuria, renal failure | HUS has MAHA on smear (schistocytes) + Shiga toxin; malaria has parasites on smear |
9. SHORT CLINICAL CASES
Case 1 - Classic Uncomplicated Malaria
"A 28-year-old male returns from a 2-week trip to Nigeria. 10 days after return, he presents with 3 days of high-grade fever with chills and rigors occurring every other day, severe headache, nausea, and myalgia. He did not take chemoprophylaxis. On examination: temperature 39.8°C, pallor, splenomegaly. Platelets are 65,000/μL."
Diagnosis: Uncomplicated malaria (P. vivax or P. falciparum)
Reasoning:
- Travel to sub-Saharan Africa without prophylaxis + incubation period of ~10 days = classic
- Alternating day fever (48-h cycle) + rigors + headache = malarial paroxysm
- Thrombocytopenia is a consistent finding; splenomegaly confirms ongoing hemolysis
- Next step: Thick and thin peripheral blood smear + RDT
Case 2 - Severe/Cerebral Malaria
"A 35-year-old woman, 20 weeks pregnant, returning from sub-Saharan Africa, presents with 4 days of high fever, and has now developed confusion and a generalized tonic-clonic seizure. GCS is 9/15. Blood glucose is 28 mg/dL. Peripheral smear shows > 5% parasitized RBCs with ring forms and banana-shaped gametocytes. Creatinine is 3.5 mg/dL."
Diagnosis: Severe P. falciparum malaria with cerebral malaria and hypoglycemia
Reasoning:
- Banana-shaped gametocytes = P. falciparum (pathognomonic)
- GCS < 11 + seizure = cerebral malaria (microvascular sequestration via PfEMP1-ICAM-1 binding)
- Hypoglycemia (< 40 mg/dL) = impaired gluconeogenesis + parasite glucose consumption
-
2% parasitemia + AKI = multiple WHO severity criteria met
- Pregnant women at HIGH risk - placental sequestration
- Treatment: IV Artesunate IMMEDIATELY; correct hypoglycemia with IV dextrose; ICU care
10. TREATMENT
A. Non-Pharmacological Treatment
- Immediate hospitalization for severe malaria
- Bed rest; mosquito netting
- Adequate hydration (oral in uncomplicated; IV with caution in severe - risk of pulmonary edema)
- Temperature management: Tepid sponging, paracetamol for fever
- Blood transfusion: Packed RBCs if Hb < 7 g/dL or < 5 g/dL with cardiovascular compromise
- Dialysis/RRT: If acute kidney injury with oliguric renal failure
- Mechanical ventilation: If ARDS develops
- ICU monitoring in severe malaria
- Treat hypoglycemia: IV 50% dextrose (10 mL/kg of 10% dextrose in children); monitor blood glucose every 4 hours (especially with quinine therapy)
- Prevention: Long-sleeved clothing, DEET repellent, insecticide-treated bed nets, indoor residual spraying, chemoprophylaxis
B. Pharmacological Treatment
Drug of Choice Summary (Exam Must-Know)
| Scenario | Drug of Choice |
|---|---|
| Uncomplicated falciparum malaria (endemic areas) | Artemether-Lumefantrine (ACT) |
| Uncomplicated falciparum malaria (USA/resource-rich) | Atovaquone-Proguanil (Malarone) or Artemether-Lumefantrine |
| Severe malaria (all species) | IV Artesunate |
| Non-falciparum malaria (P. vivax, P. ovale, P. malariae) | Chloroquine |
| Relapse prevention (P. vivax/P. ovale) | Primaquine (after G6PD testing) |
| Chemoprophylaxis in chloroquine-resistant areas | Atovaquone-Proguanil or Doxycycline or Mefloquine |
| Chemoprophylaxis in chloroquine-sensitive areas | Chloroquine |
Pharmacological Treatment Table
| Drug | Drug Group | Mechanism of Action | Indication | Standard Dose | Major Adverse Effects |
|---|---|---|---|---|---|
| Artemether-Lumefantrine (Coartem) | Artemisinin combination therapy (ACT) | Artemether: generates free radicals via heme activation → kills trophozoites. Lumefantrine: inhibits heme detoxification | First-line: Uncomplicated P. falciparum (all endemic areas per WHO) | Adults: 4 tabs (80/480 mg) at 0, 8, 24, 36, 48, 60 h (6-dose regimen) | QT prolongation; headache; nausea; dizziness |
| IV Artesunate | Artemisinin derivative | Generates reactive oxygen species via heme-activated endoperoxide bridge → rapid killing of all erythrocytic stages including schizonts | FIRST-LINE: Severe malaria (ALL species); superior to quinine (reduced mortality 35% in adults, 22.5% in children vs quinine) | 2.4 mg/kg IV at 0, 12, 24 h → then every 24 h; switch to oral ACT when stable | Delayed hemolysis (1-3 weeks post-treatment, especially after IV artesunate) |
| Chloroquine phosphate | 4-Aminoquinoline | Accumulates in parasite's digestive vacuole → inhibits heme polymerization → toxic free heme accumulates → parasite killed | Uncomplicated P. vivax, P. ovale, P. malariae; P. falciparum only in chloroquine-sensitive areas (Central America west of Panama Canal, Caribbean) | 600 mg base PO then 300 mg at 6, 24, 48 h (total 1500 mg base) | Nausea; headache; retinopathy (chronic use); cardiac arrhythmia; bitter taste; pruritus (common in Africans) |
| Primaquine | 8-Aminoquinoline | Kills hepatic hypnozoites (liver dormant stages) + gametocytes | Radical cure of P. vivax and P. ovale (prevents relapse); gametocyte clearance | 15 mg base/day for 14 days (standard); 30 mg/day for 7 days (short course) | HEMOLYTIC ANEMIA in G6PD deficiency (MUST test G6PD before use); methemoglobinemia; nausea; GI upset; CONTRAINDICATED in pregnancy |
| Tafenoquine | 8-Aminoquinoline | Same as primaquine but longer half-life | Radical cure of P. vivax relapse prevention; single dose is effective | 300 mg single dose (adults) | Hemolysis in G6PD deficiency (MUST test G6PD); psychiatric effects; |
| Atovaquone-Proguanil (Malarone) | Hydroxynaphthoquinone + DHFR inhibitor | Atovaquone: inhibits mitochondrial electron transport chain (Cyt b). Proguanil: inhibits DHFR → blocks folate synthesis | Uncomplicated falciparum (resource-rich settings); Chemoprophylaxis in resistant areas | Treatment: 4 tabs (1000/400 mg) daily x 3 days. Prophylaxis: 1 tab/day starting 1-2 days before, during, and 7 days after travel | Nausea; headache; abdominal pain; expensive; not ideal in renal failure |
| Doxycycline | Tetracycline | Inhibits bacterial-type 70S ribosome in apicoplast of parasite → disrupts parasite protein synthesis | Prophylaxis; combination partner in severe malaria if artesunate unavailable | 100 mg PO twice daily (prophylaxis) or 100 mg BID x 7 days (combination treatment) | Photosensitivity; GI irritation; esophagitis; CONTRAINDICATED in pregnancy and children < 8 years |
| Mefloquine | Quinoline methanol | Inhibits hemozoin formation (similar to chloroquine) | Chemoprophylaxis; treatment of uncomplicated falciparum where artemisinin unavailable | Treatment: 750 mg then 500 mg after 6-8 h. Prophylaxis: 250 mg/week | Severe neuropsychiatric effects (anxiety, depression, psychosis, seizures); AVOID in epilepsy, psychiatric illness, cardiac conduction defects |
| Quinine | Cinchona alkaloid | Inhibits heme detoxification → accumulates in food vacuole | Severe malaria (alternative to artesunate if unavailable); combination therapy | IV: 20 mg/kg loading dose in 5% dextrose over 4 h, then 10 mg/kg every 8 h for 7 days + Doxycycline | Cinchonism (tinnitus, deafness, blurred vision); hypoglycemia (stimulates insulin); QT prolongation; cardiac arrhythmia |
| Sulfadoxine-Pyrimethamine (SP) | Antifolate combination | Inhibits dihydropteroate synthase (sulfa) + DHFR (pyrimethamine) → blocks folate synthesis | IPTp (Intermittent Preventive Treatment in Pregnancy); NOT for treatment in most areas due to resistance | SP: 3 tabs single dose for IPTp | Stevens-Johnson syndrome; folate deficiency; resistance widespread |
Note on Artemisinin Resistance
As per Harrison's 22e (2025): Artemisinin resistance in P. falciparum (Pfkelch13 mutations → prolonged parasite clearance) has emerged in Southeast Asia (Greater Mekong Subregion) and is now spreading in East Africa (Rwanda, Uganda). Triple ACTs (combining two partner drugs) are being investigated.
11. CLINICAL PEARLS
Bedside Clues
- A patient with fever, thrombocytopenia, and travel history = MALARIA until proven otherwise
- Do NOT wait for "classic" alternating fever before testing - early falciparum malaria has continuous fever
- Examine blood smear YOURSELF - lab staff unfamiliar with malaria may miss it
- If smear negative but suspicion high: repeat smear every 12-24 h x 3 times (parasitemia fluctuates with RBC lysis cycles)
- Splenomegaly may be absent in early malaria (develops after weeks)
High-Yield Exam Facts
- P. falciparum = only species with banana/crescent-shaped gametocytes
- P. falciparum = only species with PfEMP1 knobs → sequestration → severe malaria
- P. falciparum does NOT have hypnozoites → no relapse (only recrudescence)
- P. vivax and P. ovale have hypnozoites → RELAPSE → need primaquine for radical cure
- Blackwater fever = massive hemolysis + hemoglobinuria + AKI in P. falciparum
- Quartan nephrotic syndrome = immune complex deposition in P. malariae infection
- Duffy antigen (DARC) is the receptor for P. vivax → Duffy-negative Africans are resistant to P. vivax
- IV Artesunate is superior to quinine for severe malaria (reduced mortality 22-35%)
- Hypoglycemia = caused by both parasite consuming glucose AND quinine stimulating insulin release
- Malarial retinal changes (Malarial retinopathy: white patches, vessel changes, retinal hemorrhages) are highly specific for cerebral malaria
- Thick film diagnosis: count minimum 200 WBCs; call negative only after 100-200 fields
- PfHRP2-based RDTs remain positive for weeks after infection (useful in partially treated patients)
Viva Points
- "Why does P. falciparum cause more severe disease?" → Infects ALL stages of RBCs (no age restriction), produces PfEMP1 causing sequestration, and causes highest parasitemia
- "Why test G6PD before primaquine?" → Primaquine causes oxidative hemolysis in G6PD-deficient patients (common in malaria-endemic regions - natural selection)
- "What is the prognostic marker in severe malaria?" → Plasma lactate and serum bicarbonate (HCO₃) are the best biochemical prognosticators
- "Why can't we use quinine alone?" → Recrudescence rate is high; must combine with doxycycline/clindamycin for 7 days
12. COMMON DIAGNOSTIC MISTAKES
| Mistake | Why It Happens | How to Avoid |
|---|---|---|
| Missed diagnosis in returned traveler | Clinician unaware; patient doesn't volunteer travel history | ALWAYS ask travel history in any febrile patient |
| Dismissing "negative smear" | Parasitemia fluctuates; sequestration removes parasites from peripheral blood in falciparum | Repeat smear x 3 over 36 hours if suspicion high |
| Diagnosing "viral fever" | Malaria presents with myalgia, headache, cough - looks like flu | Add malaria smear/RDT in any febrile traveler |
| Missing cerebral malaria diagnosis | Confusion confused with meningitis/encephalitis | Absence of meningism + travel history + smear positivity distinguishes it |
| Starting primaquine without G6PD testing | Emergency setting, not thought of | ALWAYS check G6PD before primaquine - can precipitate life-threatening hemolysis |
| Treating P. vivax without primaquine | Only treating blood stage with chloroquine | Without primaquine, hypnozoites persist → relapse in weeks-months |
| Using chloroquine for falciparum outside safe zones | Resistance not known | Chloroquine resistance is NOW present in most P. falciparum endemic areas except Central America and Caribbean |
| Monitoring: Missing hypoglycemia in quinine therapy | Not routine glucose monitoring | Check blood glucose every 4 h in patients on quinine, especially pregnant women and children |
| Confusing P. knowlesi with P. malariae | Identical morphology on light microscopy | Always suspect knowlesi in travelers from Malaysia/Borneo/Southeast Asia; PCR distinguishes them |
| Fluid overload in severe malaria | Wanting to treat "shock" aggressively | Non-cardiogenic pulmonary edema precipitated easily by IV fluids; give cautiously, monitor closely |
13. FIVE-MINUTE REVISION SUMMARY
DEFINITION
Protozoan infection by Plasmodium species; transmitted by female Anopheles mosquito
↓
CAUSES
5 species: P. falciparum (worst) > P. vivax > P. ovale > P. malariae > P. knowlesi
↓
PATHOPHYSIOLOGY
Mosquito bite → Sporozoites → Liver (hepatic/pre-erythrocytic stage, clinically silent)
→ Merozoites → RBCs (erythrocytic stage = CLINICAL DISEASE)
→ Trophozoites → Schizonts (PfEMP1 knobs → sequestration in falciparum)
→ RBC lysis → cytokines → FEVER | ongoing hemolysis → ANEMIA
↓
SYMPTOMS
Paroxysmal fever (cold → hot → sweating), headache, chills, myalgia, vomiting
Splenomegaly, jaundice, pallor, thrombocytopenia
↓
SEVERE MALARIA (P. falciparum flags)
Cerebral malaria (GCS < 11) | Hypoglycemia | AKI | ARDS | DIC | Blackwater fever
> 2% parasitemia | Shock | Metabolic acidosis
↓
INVESTIGATIONS
Gold standard = Thick + thin peripheral blood smear
RDT (PfHRP2) | PCR for confirmation
CBC: anemia, thrombocytopenia | Glucose (hypoglycemia!) | LFTs | Creatinine | Lactate
↓
TREATMENT
Uncomplicated falciparum: Artemether-Lumefantrine (ACT) 6-dose regimen x 3 days
Severe malaria: IV Artesunate 2.4 mg/kg at 0, 12, 24 h → then daily → switch to oral ACT
Non-falciparum: Chloroquine 1500 mg base over 3 days
Radical cure (P. vivax/ovale): + Primaquine 15 mg/day x 14 days (after G6PD test)
↓
COMPLICATIONS
Cerebral malaria | Blackwater fever | ARDS | AKI | DIC | Hypoglycemia
Splenic rupture | Severe anemia | Hyperreactive malarial splenomegaly
Quartan nephrotic syndrome (P. malariae) | Relapse (P. vivax/ovale)
Sources: Harrison's Principles of Internal Medicine 22e (2025, McGraw Hill) | Robbins & Kumar Basic Pathology | Rosen's Emergency Medicine | Goldman-Cecil Medicine International Edition | Murray & Nadel's Textbook of Respiratory Medicine | WHO Guidelines for Malaria, August 2025
Act as a World-Class Professor of General Medicine, Clinical Pharmacology, Pathology, and Medical Education. Teach me typhoid disease in a simple, exam-oriented, and clinically practical manner. For every disease, follow this format: 1. Definition - One-line exam definition - Simple explanation 2. Causes (Etiology) - Common causes - Important risk factors 3. Types / Classification - Brief explanation of each type 4. Pathophysiology - Step-by-step flowchart with arrows - Easy to understand 5. Clinical Features - Symptoms - Signs - Explain why important symptoms occur 6. Key Symptoms That Suggest the Diagnosis - Hallmark symptom - Classic clinical clues - Red flag findings 7. Laboratory Investigations Create a table: Investigation | Expected Finding | Clinical Significance Include: - CBC - Biochemistry - Disease-specific tests - Imaging findings if relevant 8. Differential Diagnosis Create a comparison table: Disease | Similar Features | Differentiating Features 9. Short Clinical Case Example format: "A 55-year-old male presents with chest pain radiating to the left arm, sweating, and breathlessness. ECG shows ST elevation in leads II, III, and aVF. Troponin-I is elevated." Diagnosis: Reasoning: Provide only 1–2 short high-yield cases. 10. Treatment A. Non-Pharmacological Treatment B. Pharmacological Treatment Create a table: Drug | Drug Group | Mechanism of Action | Indication | Dose | Major Adverse Effects For every disease mention: - Drug of Choice (DOC) - First-line drugs - Alternative drugs - Emergency drugs (if applicable) 11. Clinical Pearls - Important bedside clues - High-yield exam facts - Viva points 12. Common Diagnostic Mistakes - Frequently missed findings - Common confusion with other diseases - How to avoid errors 13. 5-Minute Revision Summary Definition → Causes → Pathophysiology → Symptoms → Investigations → Treatment → Complications Teaching Rules: - Use simple English. - Explain like teaching a final-year medical student. - Use tables and flowcharts. - Focus on practical diagnosis and treatment. - Focus on exam-oriented points. - Mention standard drug doses whenever possible. - Keep the explanation concise but complete.
Reading File
Finding Sources
Searching PubMed
"typhoid fever" AND "treatment"
Searching the Web
typhoid fever WHO guidelines 2025 treatment clinical management
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I have comprehensive, deeply authoritative content from Harrison's 22e (2025), Robbins Pathology, Tintinalli's Emergency Medicine, Sleisenger & Fordtran's GI, Bailey & Love's Surgery, and Park's PSM. Now I have everything needed to compile the full teaching module.
TYPHOID FEVER (ENTERIC FEVER) - Complete Medical Teaching Module
Sources: Harrison's Principles of Internal Medicine 22e (2025, McGraw Hill) | Robbins & Kumar Basic Pathology | Tintinalli's Emergency Medicine | Sleisenger & Fordtran's GI and Liver Disease | Bailey & Love's Short Practice of Surgery 28e | Park's Textbook of Preventive and Social Medicine
1. DEFINITION
One-line exam definition:
Typhoid fever (enteric fever) is a systemic febrile illness caused by Salmonella enterica serotype Typhi (or Paratyphi), transmitted via the fecal-oral route, characterized by prolonged stepladder fever, relative bradycardia, rose spots, and involvement of Peyer's patches in the terminal ileum.
Simple explanation:
You swallow contaminated food or water → the bacteria enter your gut, hide inside immune cells, travel to the liver, spleen, and bone marrow → re-enter the bloodstream → cause a prolonged, escalating fever with systemic symptoms. Without treatment, they destroy the gut wall, causing perforation and death.
2. CAUSES (ETIOLOGY)
Causative Organism
- Primary cause: Salmonella enterica serotype Typhi (S. Typhi) - gram-negative bacillus, facultative anaerobe
- Secondary cause (Paratyphoid): S. Paratyphi A, B, and C (milder disease)
- Humans are the ONLY natural reservoir (no animal reservoir - key exam point)
Route of Transmission
- Fecal-oral route (primary) - contaminated water, food, ice
- Contamination from chronic carrier (gallbladder colonization → bile → feces → environment)
- Raw fruits/vegetables grown in sewage-contaminated soil
- Street food, contaminated shellfish
- Sexual transmission (described in MSM)
- Health care workers from infected patients/lab specimens
Important Risk Factors
| Risk Factor | Details |
|---|---|
| Poor water/sanitation | Most important - fecal contamination of water supply |
| Endemic area travel | Indian subcontinent (India, Pakistan, Bangladesh, Nepal), Southeast Asia, Africa, Latin America |
| Street food consumption | Unwashed raw vegetables, beverages from street vendors |
| Chronic carrier contact | Household contacts of carriers |
| Reduced gastric acidity | Antacid use, PPIs, prior H. pylori infection (reduces acid barrier) |
| Young children/adolescents | Most affected in endemic areas |
| No vaccination | Unvaccinated travelers |
| Immunocompromised | HIV/AIDS - increased risk |
| Gallstones | Predispose to chronic carrier state |
3. TYPES / CLASSIFICATION
A. By Causative Agent
| Type | Organism | Features |
|---|---|---|
| Typhoid fever | S. Typhi | More severe; 10-30% mortality untreated; classic presentation |
| Paratyphoid A | S. Paratyphi A | Similar to typhoid but milder; predominantly GI symptoms |
| Paratyphoid B | S. Paratyphi B | Milder still; more diarrhea, less systemic illness |
| Paratyphoid C | S. Paratyphi C | Rare; septicemic form; cholecystitis common |
"Enteric fever" = collective term for typhoid + paratyphoid
B. By Drug Resistance Pattern (Clinically Critical - Exam)
| Type | Resistance Profile | Treatment Implication |
|---|---|---|
| Drug-sensitive | Sensitive to chloramphenicol, ampicillin, TMP-SMX | Any first-line drug works |
| MDR (Multidrug-Resistant) | Resistant to chloramphenicol + ampicillin + TMP-SMX | Use fluoroquinolone or 3rd-gen cephalosporin |
| DSC (Decreased Susceptibility to Ciprofloxacin) | Nalidixic acid-resistant; MIC ≥ 0.125 μg/mL | Fluoroquinolone clinical failure; use azithromycin or ceftriaxone |
| XDR (Extensively Drug-Resistant) | MDR + resistant to fluoroquinolones + 3rd-gen cephalosporins (ESBL-producing) | Only azithromycin or carbapenems effective |
XDR typhoid (H58 clone) emerged in Pakistan in 2016, now spreading internationally via air travel - major current concern (Harrison's 22e, 2025)
C. By Clinical Form
- Uncomplicated typhoid - typical febrile illness without organ complications
- Complicated typhoid - intestinal perforation, GI bleeding, encephalopathy, etc.
- Chronic carrier state - shedding > 1 year after infection (1-4% of cases)
4. PATHOPHYSIOLOGY
Step-by-Step Flowchart
INGESTION of contaminated food/water containing S. Typhi
(infective dose: 10³-10⁶ organisms)
↓
Bacteria overcome gastric acid barrier
(H. pylori, antacids → increased susceptibility)
↓
Bacteria reach TERMINAL ILEUM
→ Penetrate intestinal epithelium via M cells overlying PEYER'S PATCHES
(M cells = specialized epithelial cells that sample gut antigens)
↓
PEYER'S PATCHES ENLARGE (Week 1)
→ Bacteria taken up by submucosal macrophages
→ Bacteria SURVIVE inside macrophages (Vi antigen resists phagocytosis)
(Typhoid nodules = macrophage aggregates in liver, spleen, bone marrow)
↓
BACTEREMIA (PRIMARY / SILENT) - lasts days
→ Bacteria carried in macrophages via lymphatics → thoracic duct → bloodstream
→ Reach LIVER, SPLEEN, BONE MARROW, GALLBLADDER, LYMPH NODES
(Reticuloendothelial system = main site of multiplication)
[Clinically silent incubation period: 10-14 days]
↓
SECONDARY BACTEREMIA (Week 1-2) - CLINICAL ILLNESS BEGINS
Massive release of bacteria + endotoxin (LPS) into bloodstream
→ Endotoxin activates cytokine cascade (TNF-α, IL-1, IL-6)
→ PROLONGED HIGH FEVER, headache, malaise
↓
WEEK 2-3: INTESTINAL PHASE
Bacteria re-enter gut via bile (from gallbladder colonization)
→ Re-infect Peyer's patches (now sensitized = hypersensitivity reaction)
→ INTENSE INFLAMMATION → Peyer's patches enlarge → plateau-like elevations
→ Mucosal shedding → OVAL ULCERS along long axis of ileum
↓
COMPLICATIONS (if untreated):
├── PERFORATION (Week 3): Ulcer penetrates all layers → free perforation
│ → Peritonitis, septic shock (most deadly complication)
├── HEMORRHAGE: Eroded blood vessel under ulcer → GI bleed
├── CONTINUED BACTEREMIA: Seeding of organs
│ → Cholecystitis, pneumonia, meningitis, osteomyelitis, myocarditis
└── CHRONIC CARRIER STATE: Bacteria persist in gallbladder (esp. with gallstones)
CONVALESCENCE (Week 4+): Fever resolves; risk of RELAPSE in 5-10%
Why Relative Bradycardia Occurs
Endotoxin from S. Typhi directly depresses the sinoatrial node → heart rate does not rise proportionally with fever ("Faget's sign" = dissociation between fever and pulse rate) Expected: fever by 1°F → HR rises by 10 bpm; in typhoid, this does NOT happen
Pathological Changes (Robbins & Kumar)
- Peyer's patches: Enlarged to plateau-like elevations (up to 8 cm) → mucosal shedding → oval ulcers along the LONG AXIS of ileum (contrast with TB: transverse ulcers)
- Spleen: Red pulp expansion; phagocyte hyperplasia
- Liver: Typhoid nodules (macrophage aggregates with focal necrosis)
- Bone marrow: Hyperplastic with typhoid nodules; hence bone marrow culture is most sensitive
5. CLINICAL FEATURES
The Classic 4-Week Course (Week-by-Week - High Yield!)
WEEK 1 - "Invasion Stage"
Gradual onset: fever (stepladder pattern - rises by 1°C each day)
Headache (80%), malaise, myalgia, dry cough (30%), anorexia (55%)
Fever reaches 39-40°C by end of Week 1
Constipation more common than diarrhea (30% constipated)
↓
WEEK 2 - "Fastigium (Peak) Stage"
Sustained high fever (plateau): 39-40.5°C
Relative bradycardia (pulse-temperature dissociation)
ROSE SPOTS (30-70% of fair-skinned patients): 2-4mm, faintly pink
maculopapular spots, blanch on pressure, on trunk/abdomen
Hepatosplenomegaly develops
Abdominal distension, "pea-soup" diarrhea (or constipation)
↓
WEEK 3 - "Amphibolic Stage" - MOST DANGEROUS
High fever continues
COMPLICATIONS PEAK:
• Intestinal perforation (most feared - sudden severe abdominal pain, signs of peritonitis)
• GI hemorrhage (passing black tarry stools)
• Encephalopathy / "typhoid state" (confusion, delirium)
• Myocarditis, cholecystitis, pneumonia
↓
WEEK 4 - "Defervescence / Resolution"
Gradual resolution if treated
Risk of RELAPSE (5-10%) in 2-3 weeks after apparent recovery
Symptoms (Harrison's 22e - Actual Frequencies)
| Symptom | Frequency |
|---|---|
| Headache | 80% (most common symptom) |
| Prolonged fever | > 75% |
| Chills | 35-45% |
| Anorexia | 55% |
| Cough (dry) | 30% |
| Abdominal pain | 30-40% |
| Nausea | 18-24% |
| Vomiting | 18% |
| Diarrhea | 22-28% |
| Constipation | 13-16% (classic, early) |
| Myalgia | 20% |
| Arthralgia | 2-4% |
Signs (Clinical Examination)
| Sign | Details |
|---|---|
| Stepladder fever | Rises ~1°C/day over 1st week, then sustained plateau |
| Relative bradycardia | Pulse-temperature dissociation (Faget's sign) |
| Rose spots | 2-4mm faintly erythematous maculopapular lesions on trunk; blanch on pressure; appear Week 2; last 3-4 days; more visible on fair skin |
| Hepatomegaly | Tender; typhoid nodules in liver |
| Splenomegaly | Soft, tender splenomegaly (Week 2 onward) |
| Coated tongue | Central brown/yellow coating, clean edges |
| Abdominal distension | Especially in severe disease |
| Dicrotic pulse | Double-peaked pulse (rare, low pulse volume) |
| Deafness | Rare complication; nerve deafness |
Why Key Symptoms Occur
| Symptom | Mechanism |
|---|---|
| Stepladder fever | Gradual increase in bacteremia + endotoxin release → hypothalamic set-point rises progressively |
| Relative bradycardia | S. Typhi endotoxin directly depresses SA node |
| Rose spots | Bacterial emboli in dermal capillaries → perivascular inflammation |
| Constipation (early) | Peyer's patch inflammation → impaired peristalsis |
| "Pea-soup" diarrhea (late, Week 2-3) | Ulceration of Peyer's patches → profuse watery stool |
| Splenomegaly | Reticuloendothelial hyperplasia + bacterial colonization |
| Headache | Endotoxin-mediated cytokine release acting on CNS |
| Dry cough | Bronchitis from bacteremia seeding; endotoxin |
6. KEY SYMPTOMS THAT SUGGEST THE DIAGNOSIS
Hallmark Symptom
Prolonged stepladder fever (> 5-7 days) + relative bradycardia in a patient from or returning from an endemic area
Classic Clinical Clues (The "Typhoid Triad")
- Prolonged fever (> 1 week, stepladder pattern rising to 40°C)
- Relative bradycardia (pulse doesn't rise with fever)
- Rose spots on the trunk (pathognomonic when present)
Plus: splenomegaly + coated tongue + constipation → strongly suggests typhoid
Red Flag Findings (Complications - Call ICU)
| Red Flag | Significance |
|---|---|
| Sudden severe abdominal pain + rigidity | Intestinal perforation (peritonitis) - surgical emergency |
| Melena / fresh rectal bleeding | Intestinal hemorrhage |
| Altered consciousness / confusion | Typhoid encephalopathy or meningitis |
| Shock | Perforation, hemorrhage, or septic shock |
| Persistent fever despite 5 days of antibiotics | MDR/XDR typhoid; wrong diagnosis |
| Hepatomegaly + jaundice + elevated LFTs | Typhoid hepatitis |
| Chest pain + arrhythmia | Typhoid myocarditis |
| Seizures | Typhoid encephalopathy / meningitis |
7. LABORATORY INVESTIGATIONS
| Investigation | Expected Finding | Clinical Significance |
|---|---|---|
| CBC - Hemoglobin | Normal or mild anemia; significant anemia with GI hemorrhage | GI blood loss or hemolysis in severe disease |
| CBC - WBC (Total Count) | Leukopenia (2000-6000/μL) + neutropenia - classic; 15-25% of cases | Key diagnostic clue; leukocytosis suggests perforation or secondary infection |
| CBC - Platelets | Often mildly reduced; severe thrombocytopenia in DIC | Consumed in DIC complication |
| ESR | Low/normal despite high fever (Westergren method) | Paradoxically low ESR in typhoid = diagnostic clue (contrast with other bacterial infections) |
| CRP | Elevated | Non-specific marker of inflammation |
| Blood Culture | S. Typhi grows in 40-60% (Week 1 best yield) | Gold standard for definitive diagnosis; sensitivity reduces after antibiotics or beyond Week 1 |
| Bone Marrow Culture | S. Typhi in ~80% sensitivity | Most sensitive test overall; remains positive even after 5 days of antibiotics - use when blood culture negative |
| Stool Culture | Positive Week 2-3 (negative in 60-70% in Week 1) | Useful in later disease; also identifies chronic carriers |
| Urine Culture | Positive Week 2-3 in ~25-30% | Less sensitive; useful as adjunct |
| Widal Test | Rise in O antigen titer ≥ 1:80-1:160 (acute); rise in H antigen titer | Presumptive test; single titer unreliable (cross-reactions with other Salmonella, prior vaccination); paired sera (4-fold rise in 2 weeks) more meaningful |
| Typhidot / Tubex (Rapid IgM/IgG test) | IgM antibodies to S. Typhi O9 antigen (Tubex); IgM/IgG to 50kDa OMP (Typhidot) | Sensitivity ~70-80%, specificity ~80-90%; not accurate enough to replace blood culture; useful in resource-limited settings |
| PCR (Blood) | Detects S. Typhi DNA | Sensitivity 40-100%; increasingly available post-COVID; highest sensitivity |
| Liver Function Tests | Mild elevation of AST/ALT (3x ULN) | Hepatic involvement (typhoid nodules); severe elevation = typhoid hepatitis |
| Bilirubin | Mildly elevated | Hepatic involvement |
| Serum Albumin | Low in prolonged disease | Acute phase response |
| Blood Glucose | Usually normal; hypoglycemia in severe/toxic disease | Monitor in severe typhoid |
| Coagulation (PT/PTT) | Prolonged in DIC | Complication of severe typhoid |
| Chest X-Ray | Usually normal; may show pneumonia (10-15%) | Typhoid pneumonia; aspirate pneumonia with encephalopathy |
| Abdominal X-Ray / CT | Free air under diaphragm if perforated; dilated bowel loops (paralytic ileus) | Perforation = surgical emergency |
| USG Abdomen | Hepatosplenomegaly; acalculous cholecystitis | Complications |
| Duodenal String Test (Enterotest) | Culture of bile-stained string positive for S. Typhi | Can be positive when blood culture is negative; >90% sensitivity combined with blood+BM+string |
Culture Yield by Week (High-Yield Exam Table)
| Specimen | Week 1 | Week 2 | Week 3 | Week 4 |
|---|---|---|---|---|
| Blood culture | Best (40-80%) | 30-40% | 10-20% | Low |
| Bone marrow culture | 80% (any week) | 80% | 80% | 80% |
| Stool culture | Low | Best (40-60%) | Best | Decreasing |
| Urine culture | Low | Moderate | Moderate | Low |
8. DIFFERENTIAL DIAGNOSIS
| Disease | Similar Features | Differentiating Features |
|---|---|---|
| Malaria | Prolonged fever, endemic area travel, splenomegaly, headache | Periodic fever with rigors; thrombocytopenia; positive blood smear/RDT; hemolytic anemia; NO rose spots |
| Dengue fever | Fever, headache, myalgia, leucopenia, thrombocytopenia | Severe thrombocytopenia; maculopapular rash ("islands of white in sea of red"); retro-orbital pain; positive NS1/IgM; shorter duration (5-7 days) |
| Leptospirosis | Fever, headache, myalgia, hepatosplenomegaly, jaundice | Exposure to contaminated water; severe calf muscle tenderness; conjunctival suffusion; Weil's disease (jaundice + AKI); serology |
| Brucellosis | Undulant fever, splenomegaly, leukopenia, travel history | Occupational exposure (livestock, dairy); undulant fever; positive Brucella serology/culture; back pain, sacroiliitis |
| Viral hepatitis (A/E) | Fever, hepatomegaly, jaundice, anorexia, nausea | Markedly elevated LFTs (10-100x ULN); positive serology (IgM anti-HAV/anti-HEV); no splenomegaly early; no rose spots |
| Infectious mononucleosis | Fever, splenomegaly, hepatomegaly, lymphadenopathy | Young adults; exudative pharyngitis; posterior cervical LN; positive Monospot/EBV IgM; atypical lymphocytes; NO rose spots |
| Rickettsial infection (Typhus) | Stepladder fever, headache, rash, splenomegaly | Rash starts peripherally (wrists, ankles → trunk); history of louse/tick bite; Weil-Felix reaction positive; eschar (scrub typhus) |
| Miliary TB | Prolonged fever, splenomegaly, hepatomegaly, leukopenia | Weight loss prominent; night sweats; miliary pattern on CXR; elevated ADA; positive TB tests |
| Pyogenic/Amoebic Liver Abscess | Fever, hepatomegaly, RUQ pain | Localized RUQ tenderness; ultrasound shows abscess; single large cavity (amoebic) or multiple (pyogenic) |
| Appendicitis | Abdominal pain (Week 3 typhoid mimics appendicitis) | Appendicitis: rapid onset, localized RIF tenderness, high WBC; Typhoid: leucopenia, prior fever history, rose spots |
9. SHORT CLINICAL CASES
Case 1 - Classic Uncomplicated Typhoid Fever
"A 22-year-old male college student returns from a 3-week visit to Pakistan. He presents with 10 days of progressive fever reaching 39.5°C, severe frontal headache, dry cough, and anorexia. He denies diarrhea but reports constipation. On examination: temperature 39.8°C, pulse 82 bpm (expected ~110 bpm for this fever), soft splenomegaly, and 3 faint pink blanching spots on his abdomen. WBC = 3,200/μL. Blood culture is pending."
Diagnosis: Typhoid fever (Salmonella Typhi infection)
Reasoning:
- Travel to Indian subcontinent + 10 days of progressive stepladder fever = classic history
- Relative bradycardia (fever 39.8°C but pulse only 82 - should be ~110) = Faget's sign, pathognomonic clue
- Rose spots on trunk = classic; faint pink blanching macules
- Leukopenia (WBC 3,200) despite high fever = typhoid pattern (most bacterial infections cause leukocytosis)
- Dry cough + constipation (not diarrhea) = typical early typhoid
- Next step: Blood culture x 3 sets (aerobic + anaerobic); Widal test; start empiric ceftriaxone or azithromycin while awaiting sensitivity
Case 2 - Complicated Typhoid Fever with Intestinal Perforation
"A 28-year-old man from Bangladesh has been febrile for 19 days, now presents with sudden severe generalized abdominal pain and vomiting. Previously he had stepladder fever, headache, and 6 rose spots. On examination: temperature 38.2°C (fever dropped acutely), pulse 130 bpm, BP 90/60 mmHg, abdomen rigid and board-like with rebound tenderness. Abdominal X-ray shows free air under the right dome of diaphragm."
Diagnosis: Typhoid fever complicated by ileal perforation with peritonitis
Reasoning:
- Week 3 of illness (19 days) = peak period for perforation
- Sudden severe abdominal pain + rigidity + rebound = peritonitis
- Acute drop in fever at time of perforation (classic - as the body's response to intestinal perforations)
- Free air under diaphragm on X-ray = confirms perforation
- Septic shock (hypotension + tachycardia) from peritonitis
- Management: Emergency laparotomy + peritoneal washout + closure of perforation site + IV antibiotics (ceftriaxone + metronidazole) + resuscitation. Bowel resection usually avoided.
10. TREATMENT
A. Non-Pharmacological Treatment
- Hospitalization for moderate-severe disease; isolation (contact precautions - enteric precautions)
- Bed rest
- Oral/IV fluids - adequate hydration; IV fluids if vomiting/unable to take orally
- Soft, easily digestible diet (oral nutrition preferred in absence of ileus/abdominal distension); avoid high-roughage foods that risk perforation
- Antipyretics: Paracetamol for fever (avoid NSAIDs - risk of GI bleeding)
- Tepid sponging for fever
- Blood transfusion if GI hemorrhage and Hb falls significantly
- Surgical treatment (intestinal perforation):
- Emergency laparotomy
- Peritoneal washout
- Simple closure of perforation (preferred; bowel resection avoided)
- If hemodynamically unstable: exteriorize bowel, close after recovery
- Cholecystectomy for chronic gallbladder carriers who fail antibiotic eradication
- Public health notification (notifiable disease in most countries)
B. Pharmacological Treatment
Drug of Choice Summary
| Scenario | Drug of Choice |
|---|---|
| Uncomplicated typhoid (drug-sensitive) | Fluoroquinolone (ciprofloxacin/ofloxacin) |
| Uncomplicated typhoid (fluoroquinolone-resistant / Indian subcontinent) | Azithromycin (oral) |
| Severe typhoid / hospitalised | IV Ceftriaxone |
| MDR typhoid (chloramphenicol+ampicillin+TMP-SMX resistant) | Ceftriaxone or Fluoroquinolone |
| XDR typhoid (resistant to fluoroquinolones + cephalosporins) | Azithromycin or Carbapenems (meropenem) |
| Typhoid meningitis/encephalopathy or shock | Ceftriaxone + Dexamethasone |
| Chronic carrier (gallbladder) | Ciprofloxacin 750 mg BD x 4 weeks |
| Pregnancy | Ceftriaxone (fluoroquinolones and chloramphenicol avoided) |
Full Drug Table
| Drug | Drug Group | Mechanism of Action | Indication | Dose | Major Adverse Effects |
|---|---|---|---|---|---|
| Ciprofloxacin | Fluoroquinolone | Inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV → prevents DNA replication and repair → bactericidal | Drug-sensitive typhoid; chronic carrier eradication | 500 mg PO BD x 7-10 days (uncomplicated); 400 mg IV BD x 10-14 days (severe) | GI upset; tendinopathy/tendon rupture; QT prolongation; AVOID in pregnancy and children <18 yrs (articular cartilage damage); increasing resistance from Indian subcontinent |
| Ofloxacin | Fluoroquinolone | Same as ciprofloxacin | Drug-sensitive typhoid | 400 mg PO BD x 7-10 days | Same as ciprofloxacin |
| Azithromycin | Macrolide | Binds 50S ribosomal subunit → inhibits translocation → bacteriostatic (bactericidal at high concentrations) | Treatment of choice for fluoroquinolone-resistant / DSC typhoid; mild-moderate typhoid; children; first trimester pregnancy | 1 g/day PO x 5 days (adults); 20 mg/kg/day x 5-7 days (children) | Nausea, diarrhea, abdominal pain; QT prolongation (mild); good safety in pregnancy |
| Ceftriaxone | 3rd-generation Cephalosporin | Binds penicillin-binding proteins → inhibits cell wall synthesis (peptidoglycan cross-linking) → bactericidal | Severe typhoid; MDR typhoid; pregnancy; children; typhoid meningitis | 2-3 g IV once daily x 10-14 days (adults); 75-100 mg/kg/day (children) | Hypersensitivity reactions; biliary sludge (reversible); C. difficile colitis (rare); phlebitis |
| Cefixime | 3rd-generation Cephalosporin (oral) | Same as ceftriaxone | Step-down oral therapy; mild-moderate typhoid | 200 mg PO BD x 7-14 days | GI upset; higher clinical failure rate vs fluoroquinolones (may increase defervescence time) |
| Chloramphenicol | Amphenicol antibiotic | Binds 50S ribosomal subunit (23S rRNA) → inhibits peptidyl transferase → bacteriostatic | Drug-sensitive typhoid only (where resistance excluded); historically first-line DOC but largely abandoned | 500 mg PO/IV QID x 14 days | Gray baby syndrome (neonates); aplastic anemia (1:10,000-40,000 - idiosyncratic, irreversible); dose-dependent bone marrow suppression; avoid in pregnancy; resistance widespread |
| Ampicillin / Amoxicillin | Aminopenicillin | Inhibits cell wall synthesis (transpeptidase inhibition) | Drug-sensitive typhoid; pregnancy (alternative) | Ampicillin 1-2 g IV q6h x 14 days; Amoxicillin 1 g TDS PO x 14 days | Rash; GI upset; hypersensitivity; widespread resistance |
| Trimethoprim-Sulfamethoxazole (TMP-SMX / Co-trimoxazole) | Antifolate combination | TMP: inhibits DHFR; SMX: inhibits dihydropteroate synthase → blocks folate synthesis | Drug-sensitive typhoid; chronic carrier (6-12 weeks) | 800/160 mg (2 tabs) PO BD x 14 days | Bone marrow suppression; Stevens-Johnson syndrome; rash; AVOID in pregnancy (teratogenic; displaces bilirubin); widespread resistance |
| Meropenem | Carbapenem | Inhibits cell wall synthesis → bactericidal | XDR typhoid (last resort) | 1 g IV TDS | GI upset; C. difficile; seizures (high dose); cost |
| Dexamethasone | Corticosteroid | Anti-inflammatory; reduces cytokine storm; improves blood-brain barrier function | Adjunct in typhoid meningitis / encephalopathy / severe septic shock with typhoid | 3 mg/kg IV loading dose, then 1 mg/kg q6h x 48 h (Hoffman regimen) | Hyperglycemia; masking of perforation signs; risk of secondary infection |
Vaccination (Prevention)
| Vaccine | Type | Route | Schedule | Efficacy | Notes |
|---|---|---|---|---|---|
| Ty21a (Vivotif) | Live attenuated oral | Oral | 1 cap every 2 days x 4 doses | ~67% | Cold chain needed; avoid antibiotics during administration; not < 6 years; contraindicated in immunocompromised |
| Vi polysaccharide (Typherix, Typhim Vi) | Purified capsular polysaccharide | IM | Single dose; booster every 2-3 years | ~72% | Age ≥ 2 years; safe in immunocompromised |
| Typhoid Conjugate Vaccine (TCV - Typbar TCV) | Vi polysaccharide conjugated to tetanus toxoid carrier protein | IM | Single dose | ~81-87% | WHO recommended for endemic countries; approved from age 6 months; longer lasting immunity; recommended in XDR areas |
11. CLINICAL PEARLS
Important Bedside Clues
- Relative bradycardia = pulse rate lower than expected for the degree of fever → strongly suggests typhoid (also seen in brucellosis, leptospirosis)
- Rose spots are transient (3-4 days), blanch on pressure, and are easily missed in dark-skinned patients → look actively
- A patient with fever + leukopenia (not leukocytosis) should prompt typhoid consideration
- Tongue: centrally coated with brown fur but clean red edges = classic typhoid tongue
- The fever in typhoid is continuous (not periodic/intermittent like malaria)
- Always ask about antibiotic use before presentation - prior antibiotics reduce blood culture yield dramatically
- Week 3 perforation presents as sudden pain + fever DROP (paradoxical) → do NOT be reassured by fever falling
High-Yield Exam Facts
- S. Typhi is the ONLY Salmonella with humans as the sole reservoir (no animal reservoir)
- Bone marrow culture = most sensitive test overall (80%) - positive even after antibiotics
- Blood culture Week 1 = best blood culture yield (40-80%)
- Stool culture Week 2-3 = best stool culture yield
- Widal test = single titre unreliable; paired titres (4-fold rise over 2 weeks) meaningful; O agglutinins rise early (active disease); H agglutinins rise late and persist longer
- Typhoid ulcers = oval, along the long axis of ileum (TB ulcers = transverse; Crohn's = linear)
- XDR typhoid (Pakistan origin) = resistant to chloramphenicol + ampicillin + TMP-SMX + fluoroquinolones + 3rd-gen cephalosporins → treat with azithromycin or meropenem
- Chronic carrier = positive culture > 1 year; most have gallbladder involvement; treatment: ciprofloxacin 750 mg BD x 4 weeks ± cholecystectomy
- Dexamethasone significantly reduces mortality in severe typhoid with encephalopathy/shock (Hoffman study)
- Relapse rate = 5-10% (2-3 weeks after defervescence); treat same as acute episode
- Rose spots contain live S. Typhi → can be cultured
Viva Points
- "Why does typhoid cause leukopenia?" → S. Typhi infects and multiplies within mononuclear cells in bone marrow → suppresses granulopoiesis + peripheral WBC destruction
- "Why is bone marrow culture the most sensitive?" → S. Typhi concentrates in the reticuloendothelial cells of bone marrow; antibiotics penetrate poorly into macrophage vacuoles
- "What is the Widal test?" → Tube agglutination test detecting antibodies to O antigen (somatic) and H antigen (flagellar) of S. Typhi. O agglutinins indicate current infection; H agglutinins may indicate past infection or vaccination
- "What is Faget's sign?" → Relative bradycardia (pulse-temperature dissociation) = bradycardia relative to the degree of fever; seen in typhoid, yellow fever, brucellosis
- "What is the carrier state?" → 1-4% of patients shed S. Typhi in stool/urine > 1 year; gallbladder is the main reservoir; risk factors = gallstones, female sex, older age
12. COMMON DIAGNOSTIC MISTAKES
| Mistake | Why It Happens | How to Avoid |
|---|---|---|
| Diagnosing malaria and missing typhoid | Both present with fever after travel; malaria is always considered first | In endemic areas, when malaria smear is negative × 3, ALWAYS consider typhoid |
| Over-relying on Widal test | Widely available, inexpensive; but single titer is unreliable (cross-reactions, prior vaccination) | Use blood culture as standard; interpret Widal only as supportive evidence; always use paired titres |
| Missing relative bradycardia | Examiner counts pulse briefly; not compared against temperature | Always calculate expected heart rate for fever; flag if HR < fever rate |
| Missing rose spots | Transient (3-4 days only); barely visible in dark skin; only on trunk | Examine trunk and abdomen actively with tangential lighting in every febrile patient with travel history |
| Treating with wrong antibiotic (chloramphenicol for MDR/XDR typhoid) | Old habit; chloramphenicol used to be DOC | Check travel origin; Indian subcontinent/Pakistan = assume resistance; use ceftriaxone or azithromycin |
| Starting high-fibre diet in typhoid | Patients seem to recover, family/nurses resume normal diet early | Keep soft diet until complete recovery; high roughage diet → risk of intestinal perforation |
| Missing intestinal perforation | Fever drops at time of perforation → falsely reassuring; abdomen may not be initially rigid | Sudden abdominal pain in Week 3 + fever drop + tachycardia = suspect perforation; urgent AXR/erect CXR |
| Negative blood culture = ruling out typhoid | Blood culture sensitivity is only 40-60% | If suspicion high: send bone marrow culture; combine all specimens (blood + BM + stool + string test) |
| Giving ciprofloxacin for typhoid from Indian subcontinent | Fluoroquinolone is classically associated with typhoid treatment | Ciprofloxacin resistance now very high (>66% in USA travel-associated cases); use azithromycin or ceftriaxone |
| Prescribing NSAIDs for fever | Patient requests strong antipyretics | NSAIDs risk GI bleeding in already-ulcerated Peyer's patches; use paracetamol only |
13. FIVE-MINUTE REVISION SUMMARY
DEFINITION
Systemic febrile illness caused by S. Typhi; fecal-oral transmission; humans = sole reservoir
↓
CAUSES
S. Typhi (main) | S. Paratyphi A, B, C (milder = paratyphoid)
Contaminated water/food/ice; chronic carriers (gallbladder)
Risk: poor sanitation, travel to Indian subcontinent/Africa/Asia, no vaccination
↓
PATHOPHYSIOLOGY
Ingestion → M cells / Peyer's patches → macrophage invasion → lymph/blood →
RES proliferation in liver/spleen/BM → secondary bacteremia (Week 1)
→ Bile re-seeding → Peyer's patch ulceration → oval ileal ulcers (long axis)
→ Week 3: PERFORATION / HEMORRHAGE
↓
SYMPTOMS (Week-by-Week)
Week 1: Stepladder fever, headache, constipation, dry cough
Week 2: Sustained fever, relative bradycardia, rose spots, hepatosplenomegaly
Week 3: Complications - perforation, hemorrhage, encephalopathy
Week 4: Resolution (or complications if untreated)
↓
INVESTIGATIONS
Gold standard: Blood culture (Week 1; 40-80% yield)
Most sensitive: Bone marrow culture (80%, works after antibiotics)
Supportive: Widal test (paired titres), Typhidot/Tubex
CBC: Leukopenia + neutropenia (classic)
LFTs: Mildly elevated
AXR: Free air if perforation
↓
TREATMENT
Drug-sensitive: Ciprofloxacin 500 mg BD PO x 10 days
Fluoroquinolone-resistant / Indian subcontinent: Azithromycin 1 g/day x 5 days
Severe: Ceftriaxone 2-3 g IV daily x 10-14 days
XDR: Azithromycin or Meropenem
Encephalopathy/Shock: Ceftriaxone + Dexamethasone
Perforation: Surgery (washout + closure) + IV antibiotics
↓
COMPLICATIONS
Intestinal perforation (Week 3, most dangerous) | GI hemorrhage
Typhoid encephalopathy | Myocarditis | Cholecystitis | Pneumonia
Bone marrow suppression | DIC | Relapse (5-10%) | Chronic carrier state (1-4%)
Key Exam Memory Aids:
- "Typhoid = CONTINUOUS stepladder fever + RELATIVE bradycardia + ROSE spots + LEUKOPENIA"
- Culture yield: Blood (Week 1) → Stool (Week 2-3) → Bone Marrow (any time, most sensitive)
- Resistance: Drug-sensitive → Fluoroquinolone | MDR → Ceftriaxone | XDR → Azithromycin/Meropenem
- Perforation = Week 3 + sudden pain + fever DROP + board-like abdomen + free air on AXR = Surgery
Sources: Harrison's Principles of Internal Medicine 22e (2025) | Robbins & Kumar Basic Pathology | Tintinalli's Emergency Medicine | Sleisenger & Fordtran's GI and Liver Disease | Bailey & Love's Surgery 28e | Park's Textbook of Preventive and Social Medicine
This is a shared conversation. Sign in to Orris to start your own chat.